SURVEYING PLASMA LEVELS OF TNF ALPHA AND INTERLEUKIN 6 IN LUPUS NEPHRITIS

Thị Ngọc Nguyễn1,2,, Thu Hương Nguyễn2, Thị Thanh Bình Dương3, Việt Thắng Lê1
1 Vietnam Military Medical Academy
2 Vietnam National Children's Hospital.
3 Vietnam National Children's Hospital

Main Article Content

Abstract

Objectives: To investigate plasma levels of TNF-alpha, IL-6, and its correlation between TNF-alpha, IL-6 levels with some characteristics of kidney injury in pediatric lupus nephritis. Patients and Methods: Cross-sectional descriptive study compared with the healthy control group. 117 children (87 patients with lupus nephritis and 30 healthy control children) from 9/2019 to 9/2022 at the National Children's Hospital. Results: Mean age of the patient group was 10.94 ± 2.1; 81.6% were female. The median level of plasma TNF-alpha was 4.73 ng/L. It was higher in the disease group than in the healthy control group (3.54 ng/L), p< 0,001. there was a 47.1% increase in TNF-alpha level in LN compared with the control group. The median level of plasma IL6 was 3.19 ng/L, higher than the control group (1.14 ng/L), p < 0.001. the proportion of children with increased IL-6 levels compared to the control group was 56.3%. Elevated levels of TNF-alpha and IL-6 were associated with disease severity through the SLEDAI score. The group of severe and very severe pediatric patients had higher levels of TNF-alpha, IL-6, and the rate of increase level than the group of patients with mild and moderate disease, p<0.001. Conclusions: Elevated plasma levels of TNF-alpha and IL-6 are relatively common and are associated with the severity of pediatric lupus nephritis.

Article Details

References

1. Bùi Song Hương (2019), Nghiên cứu mối liên quan giữa kháng thể nucleosome và C1q với mức độ hoạt động bệnh và tổn thương thận trong Lupus ban đỏ hệ thống ở trẻ em, Luận án tiến sỹ Y học chuyên ngành Nhi Khoa, Đại học Y Hà nội.
2. Alaa A Sabry, et al (2005): Proinflammatory cytokine (TNF alpha and IL-6) in Egyptian SLE patients with lupus nephritis Is it correlated with disease activity? Eur J Gen Med; 2(4):153-158.
3. Aringer M, Zimmermann C, Graninger WB et al (2002): TNF-α is an essential mediator in lupus nephritis. Arthritis Rheum; 46:3418-9.
4. Ernest H. Choy, et al (2020): Translating IL-6 biology into effective treatments. Rheumatology. Volume 16 | June.
5. Levy DM, Kamphuis S (2012): Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am;59:345-64.
6. Lewandowski LB, Schanberg LE, Thielman N, et al (2017): Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.Lupus; 26(2), 186-194.
7. Yasunori Iwata, et al (2011): The Role of Cytokine in the Lupus Nephritis. BioMed Research International.